Compare · PHR vs V
PHR vs V
Side-by-side comparison of Phreesia Inc. (PHR) and Visa Inc. (V): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PHR and V operate in Real Estate (Real Estate), so they compete in similar markets.
- V is the larger of the two at $686.36B, about 963.9x PHR ($712.1M).
- Over the past year, PHR is down 62.7% and V is up 9.4% - V leads by 72.0 points.
- V has been more active in the news (8 items in the past 4 weeks vs 5 for PHR).
- Both have 25 recent analyst ratings on file.
- Company
- Phreesia Inc.
- Visa Inc.
- Price
- $11.51-1.71%
- $384.06+0.45%
- Market cap
- $712.1M
- $686.36B
- 1M return
- +8.18%
- +6.01%
- 1Y return
- -62.68%
- +9.35%
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 5
- 8
- Recent ratings
- 25
- 25
Phreesia Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.
Visa Inc.
Visa Inc. operates as a payments technology company worldwide. The company facilitates digital payments among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. In addition, the company offers card products, platforms, and value-added services. It provides its services under the Visa, Visa Electron, Interlink, VPAY, and PLUS brands. The company was founded in 1958 and is headquartered in San Francisco, California.
Latest PHR
- President, Network Solutions Linetsky David covered exercise/tax liability with 182 shares (SEC Form 4) (tax liability)
- SEC Form SCHEDULE 13G filed by Phreesia Inc.
- Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
- Director Munson Gillian was granted 685 shares, increasing direct ownership by 1% to 66,789 units (SEC Form 4)
- Director Goldstein Lainie was granted 377 shares, increasing direct ownership by 0.53% to 70,862 units (SEC Form 4)
- Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies
- MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider
- President, Network Solutions Linetsky David covered exercise/tax liability with 69 shares (SEC Form 4) (tax withholding)
- Principal Accounting Officer Hui Yvonne covered exercise/tax liability with 937 shares and sold $13,617 worth of shares (1,247 units at $10.92) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 21,724 units (SEC Form 4) (tax withholding)
- Director Egbuonu-Davis Lisa sold $5,735 worth of shares (536 units at $10.70) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 37,780 units (SEC Form 4)
Latest V
- Bluefin Collaborates with Visa to Deliver Unified Card-Present Acceptance Through Visa Acceptance Solutions
- PRESIDENT, TECHNOLOGY Taneja Rajat sold $6,650,860 worth of shares (17,927 units at $371.00), decreasing direct ownership by 7% to 232,112 units (SEC Form 4)
- Chief Executive Officer Mcinerney Ryan exercised 5,875 shares at a strike of $134.76 and sold $2,161,236 worth of shares (5,875 units at $367.87) as part of a pre-agreed trading plan (SEC Form 4)
- Visa to Participate in Upcoming Investor Conference
- GBL CORP CONTROLLER, CAO Andreski Peter M converted options into 4,170 shares and covered exercise/tax liability with 1,714 shares, increasing direct ownership by 32% to 10,238 units (SEC Form 4)
- CHIEF FINANCIAL OFFICER Suh Chris converted options into 15,289 shares and covered exercise/tax liability with 6,992 shares, increasing direct ownership by 84% to 18,169 units (SEC Form 4)
- New Visa Data Shows FIFA World Cup 2026™ Drove Spending Surges of Up to 24.6% in Toronto and Vancouver
- Visa to Acquire BioCatch
- VICE CHAIR, CHF PPL & CORP AFF Mahon Tullier Kelly exercised 37,281 shares at a strike of $109.82 and sold $20,902,340 worth of shares (57,272 units at $364.97), decreasing direct ownership by 29% to 49,662 units (SEC Form 4)
- SEC Form 10-Q filed by Visa Inc.